Handbook of Cannabis and Related Pathologies

Editor/Author Preedy, Victor
Publication Year: 2017
Publisher: Elsevier Science & Technology

ISBN: 978-0-12-800827-0
Category: Science - Botany
Image Count: 415
Book Status: Pending
Predicted Release Month: Sept 2019
Table of Contents

Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment is the first book to take an interdisciplinary approach to the understanding of cannabis use and misuse.

Share this

Table of Contents

  • List of Contributors
  • Preface
  • I Setting the Scene, Botanical, General and International Aspects
  • The Cannabis Plant: Botanical Aspects
  • The Biosynthesis of Cannabinoids
  • Increasing Plant Concentrations of THC and Implications on Health Related Disorders
  • Age as a Predictor of Cannabis Use
  • Lifetime Cannabis Use and Cognition in Psychosis Spectrum Disorders
  • A Profile of Synthetic Cannabinoid Users
  • Dual Disorders in Cannabis Misuse
  • Cannabis Use and Cognitive Function
  • Cannabis, Migration, and Psychosis Onset
  • The Global Epidemiology and Disease Burden of Cannabis Use and Dependence
  • International Aspects of Cannabis Use and Misuse: the Australian Perspective
  • International Aspects of Cannabis Use and Misuse: Egypt
  • Cannabis Body Packing: A Caribbean Perspective
  • Tetrahydrocannabinol Concentration and Genetic Characterization of Cannabis
  • II Personal, Social and Community Aspects of Cannabis use
  • Gender Differences in Cannabis Use Disorders
  • The Role of Age in the Onset and Further Development of Cannabis Use Disorders
  • Effects of Cannabis Use on Neurocognition in Adolescents and Emerging Adults
  • Correlates and Consequences of Prenatal Cannabis Exposure (PCE): Identifying and Characterizing Vulnerable Maternal Populations and Determining Outcomes for Exposed Offspring
  • Cannabis and Clubbing: Relevance of Cannabis and Polydrug Use in the Clubbing Culture Today
  • Cannabis and Sexual Behavior
  • Friendships and Cannabis Use
  • Students’ Knowledge of Cannabis
  • Childhood Trauma and Cannabis: Risk Factors in Severe Mental Disorders?
  • Parent's Influence on Children's Cannabis Use
  • Cannabis Users and Premorbid Intellectual Quotient
  • Cannabis and Traffic Accidents
  • Cannabis Use in Youth Subcultures
  • III Cannabis, Behavior, Psychopathology and Neuropathology
  • Drug-Related Pictures, Attentional Bias, and Cannabis Use
  • Cannabis Use and First-Episode Psychosis Patients (FEP)
  • Cannabis, Associative Memory, fMRI, and the Implicit Association Test
  • Stress Response in Cannabis Users and Psychosis
  • Motivation in Chronic Cannabis Use
  • Cannabis Use and Its Association to Mental Illness: A Focus on Mood and Anxiety Disorders
  • Cannabis Use and Well-Being
  • Craving and Cannabis: A Potential Paradox
  • Delta-9-Tetrahydrocannabinol and Catalepsy-Like Immobilization
  • The Interactive Nature of Cannabis and Schizophrenia Risk Genes
  • Neuroimaging Findings in Adolescent Cannabis Use and Early Phase Psychosis
  • Cannabis Smoking in Adult Schizophrenia: A Cognitive and Functional Magnetic Resonance Imaging Perspective
  • The Long-Lasting Effects of Cannabis Use on Movement and Brain Regions that Control Movement
  • Assessment of Cannabis Acute Effects on Driving Skills: Laboratory, Simulator, and On-Road Studies
  • Chronic Cannabis Use and Axonal Fiber Connectivity
  • Microglial Activation and Cannabis Exposure
  • Cannabis and Psychosis: Correlation, Causality, and Consequences
  • Cannabis Use in Bipolar Disorder
  • Cannabis Use in Epilepsy—Risks and Benefits
  • Cannabis, Cannabinoids, and Visceral Pain
  • Cannabis and Postoperative Analgesia
  • Aggressive Behavior and Cannabis Use
  • COMT Genotypes, Cannabis Use, and Psychosis: Gene-Environment Interaction Evidence from Human Populations, and Its Methodological Concerns
  • Neuroimaging and Genetics of the Acute and Chronic Effects of Cannabis
  • Gray Matter, Lateral Ventricle Volumes, and Executive Functioning in Cannabis Users with First-Episode Psychosis
  • Cannabis Use and Attention-Deficit/Hyperactivity Disorder: Potential Moderators
  • IV Cannabis, Organs, Tissues and Non-cns Aspects
  • Chronic Cannabis Abuse and Thyroid Function
  • Cannabis Hyperemesis Syndrome
  • Cannabis and Cannabinoids and the Effects on Gastrointestinal Function: An Overview
  • Cardiovascular Effects of Cannabis Usage
  • Cannabis and Stroke
  • Cannabis Smoking and the Lung
  • Cannabis and Hepatic Injury
  • Cannabis Allergy: More Than a Bad Trip
  • Marijuana and Breastfeeding
  • Hypocretins/Orexins and Addiction: Role in Cannabis Dependence
  • Regulatory Role of Cannabinoids for Skin Barrier Functions and Cutaneous Inflammation
  • Cannabis and Oral Health: Deleterious Effects on Periodontitis and Dental Implants
  • Does Cannabis Use Increase the Risk of Developing Cancer in Humans?
  • Cannabis and the Use of Amphetamine-Like Substances
  • V Pharmacology and Cellular Activities of Cannabinoids and Endocannabinoids
  • Cannabinoids and the Cannabinoid Receptors: An Overview
  • Signaling and Regulation of the Cannabinoid CB1 Receptor
  • Allosteric Modulation of the Cannabinoid CB1 Receptor
  • Polymorphisms of the CB2 Cannabinoid Receptor
  • Chemistry of Cannabinoid Receptor Agonists
  • The Endocannabinoid System as a Target for New Antiseizure Drugs
  • Pharmacological Aspects of Anandamide and 2-Arachidonoyglycerol as Bioactive Lipids
  • Pharmacological Aspects of NMDA Receptors, mGluR5, and Endocannabinoids
  • Peripheral CB1 Receptors and Ghrelin in Feeding Regulation: Pharmacological Implications
  • Pharmacological Aspects of Novel Antiobesity Agents Related to Cannabinoids
  • Cannabinoid Reward and Dependence: Focus on the Main Psychoactive Ingredients of Marijuana in Preclinical Studies
  • Peroxisome Proliferator Activated Receptors and Cannabinoids
  • The Protein–Protein Interactions of Cannabinoid Receptor Interacting Protein 1a (CRIP1a) and Cannabinoid 1 Receptor: The Molecular Mechanism Study Through an Integrated Molecular Modeling Approach
  • Synthetic Cannabinoids: a Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability
  • Cannabinoid Signaling in Glioma Cells and Therapeutic implications
  • VI Effects of Specific Natural and Synthetic Cannabinoids
  • The Role of 5-HT1A Receptor, and Nausea and Vomiting Relief by Cannabidiol (CBD), Cannabidiolic Acid (CBDA), and Cannabigerol (CBG)
  • Genetic and Molecular Aspects of Addiction with Tetrahydrocannabinol
  • Effects of Δ9-Tetrahydrocannabinol in Human Breast Cancer
  • Δ9-THC and COX-2 Signaling
  • Cannabinoids and the Addictive Effects of Nicotine
  • Cannabinoid Regulation of Intraocular Pressure: Human and Animal Studies, Cellular and Molecular Targets
  • Ocular Delivery of Tetrahydrocannabinol
  • The Role of γ-Aminobutyric Acid in the Interoceptive Effects of Oral Δ9-Tetrahydrocannabinol in Humans
  • The Role of Δ9-Tetrahydrocannabinol in Diabetes Mellitus
  • Cannabidiol: An Overview of its Antipsychotic Properties
  • Cannabidiol for the Treatment of Epilepsy: An Overview of Possible Mechanisms of Action and Preclinical and Human Studies
  • Cannabidiol and Neuroprotection: Evidence from Preclinical Studies
  • Cannabinoids as Potent Inhibitors of Human CYP1 Enzymes
  • The Synthetic Analog of Δ9-Tetrahydrocannabinol (THC): Nabilone. Pharmacology and Clinical Application
  • Synthetic Cannabinoids in Dementia
  • Synthetic Cannabinoid Receptor Agonists (Spice) as New Recreational Psychoactive Substances
  • Accidents and Synthetic Cannabinoids in Blood of Drivers
  • Cannabidiol as an Antioxidant
  • The Anxiolytic Effects of Cannabidiol (CBD)
  • New Ethological and Morphological Perspectives for the Investigation of Panicolytic-Like Effects of Cannabidiol
  • Spice Use Among United States Military Personnel
  • VII Medicinal Cannabis use
  • Cannabis and Synthetic Cannabinoids for Cancer Patients: Multiple Palliative Indications Together With Promising Laboratory Antineoplastic Effects
  • The Use of Medical Marijuana in the Treatment of Psychiatric Disorders
  • Beneficial Effects of Cannabis and Related Compounds on Sleep
  • Cannabinoid-Based Medicines for the Treatment of Gilles de la Tourette Syndrome
  • Cannabidiol and Multiple Sclerosis
  • Cannabinoids and Their Effects on Painful Neuropathy
  • Cannabis for Basal Ganglia Disorders (Parkinson Disease and Huntington Disease)
  • Medical Cannabis for the Treatment of Inflammatory Bowel Disease
  • Cannabidiol for the Treatment of Drug Use Disorders
  • Cannabinoids and Effects on the Gastrointestinal Tract: A Focus on Motility
  • Potential Medical Uses of Cannabigerol: A Brief Overview
  • Cannabis Use in Fibromyalgia
  • VIII Screening, Diagnosis, and Treatment
  • The Cannabis Abuse Screening Test (CAST) and Its Applications
  • Screening of Synthetic Cannabinoids
  • On-Site Drug Testing for Cannabis
  • Cannabinoids in Oral Fluid: Identification and Interpretation of Analytical Results
  • Cannabinoids in Exhaled Breath
  • Barriers to Treatment Seeking for Cannabis Dependence
  • Pharmacotherapies for Cannabis Use Disorders
  • Self-Initiated Cannabis Use Cessation in Adolescents and Emerging Adults
  • Treating Cannabis-Dependent Adolescents with Family Therapy: The case of Multidimensional Family Therapy
  • Cognitive Behavioral Therapy in Cannabis Use Disorder
  • The Cannabis Withdrawal Syndrome— Symptoms and Time Course
  • School-Based Cannabis Prevention Programs
  • The CapOpus Trial for Cannabis Use Disorders
  • Treating Cannabis Use Disorders Through Technology-Assisted Interventions: the Telephone and Internet
  • Reducing Cannabis Use With a Real-Time Intervention Using Mobile Technology
  • Short Instruments to Screen for “Problematic” Cannabis Use in General Population Surveys
  • Self-report of Cannabis Use
  • CANDIS Program: Modular Treatment of Cannabis Use Disorders
  • Engaging Cannabis Users in Treatment
  • Cannabis Neuropathology Resources and Recommended Reading